SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-040510
Filing Date
2021-08-04
Accepted
2021-08-04 08:09:37
Documents
84
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q urgn-10q_20210630.htm   iXBRL 10-Q 2649143
2 EX-31.1 urgn-ex311_8.htm EX-31.1 20371
3 EX-31.2 urgn-ex312_10.htm EX-31.2 20403
4 EX-32.1 urgn-ex321_7.htm EX-32.1 9448
5 EX-32.2 urgn-ex322_14.htm EX-32.2 9459
  Complete submission text file 0001564590-21-040510.txt   8137355

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA urgn-20210630.xsd EX-101.SCH 64384
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20210630_cal.xml EX-101.CAL 53747
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20210630_def.xml EX-101.DEF 120666
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20210630_lab.xml EX-101.LAB 389072
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20210630_pre.xml EX-101.PRE 288529
11 EXTRACTED XBRL INSTANCE DOCUMENT urgn-10q_20210630_htm.xml XML 1373031
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 211142418
SIC: 2834 Pharmaceutical Preparations